Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators

Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators

Background: Implantable cardioverter-defibrillators (ICDs) are an effective treatment in some patients with inherited heart disease, including inherited channelopathies, yet they have also been shown to impact patients’ psychological health. Objective: We sought to improve understanding of the level...

Full description

Bibliographic Details
Main Authors:	Sajya M. Singh, BS, Brittney Murray, MS, CGC, Crystal Tichnell, MGC, Rebecca McClellan, CGC, MGC, Cynthia A. James, PhD, CGC, Andreas S. Barth, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	Heart Rhythm O2
Subjects:	Anxiety Brugada syndrome Cardiac electrophysiology Depression Implantable cardioverter-defibrillator (ICD) Inherited heart disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666501821001100

Similar Items

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
by: Sharen Lee, et al.
Published: (2020-03-01)

Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention
by: Aimé Bonny, et al.
Published: (2017-01-01)

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
by: Sing-Chien Yap, MD, PhD, et al.
Published: (2015-05-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
by: Yasunobu Yamagishi, et al.
Published: (2022-06-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)

Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: A single center experience
by: Jorat MV, et al.
Published: (2007-01-01)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
by: Yasuhisa Nakao, et al.
Published: (2020-03-01)

Successful repositioning of the subcutaneous implantable cardioverter‐defibrillator lead to avoid inappropriate shock
by: Hiroshi Fukunaga, et al.
Published: (2023-02-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
by: Begisbayev T, et al.
Published: (2022-10-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)

Syncope and loss of consciousness after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: Prevalence and characteristics in long-term follow-up
by: Saori Asada, MD, PhD, et al.
Published: (2023-10-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold
by: Yasushi Wakabayashi, et al.
Published: (2019-02-01)

Implantable cardioverter-defibrillators step by step : an illustrated guide /
by: 439461 Stroobandt, Roland X., et al.
Published: (2009)

A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia
by: Kosuke Aoki, et al.
Published: (2015-12-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Psychological effects of implantable cardioverter defibrillator shocks. A review of study methods.
by: Gian Mauro eManzoni, et al.
Published: (2015-02-01)

Delivering an efficient and effective support group for patients with implantable cardioverter-defibrillators (ICDs): patient perspectives of key concerns and predictors of inclination to attend
by: Kathryn Murray, et al.
Published: (2021-07-01)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
by: Mohammad Reza Dehghani, et al.
Published: (2006-01-01)

Implantable cardioverter-defibrillator in a patient with dextrocardia situs inversus
by: Mehrdad Saravi, et al.
Published: (2016-10-01)

Comparing of Cognitive Emotion Regulation Strategies in Patients with Coronary Artery, Implantable Cardioverter Defibrillator Recipients and Normal Subjects
by: Samira Eram, et al.
Published: (2015-11-01)

Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series
by: Viveka Kumar, et al.
Published: (2022-04-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator
by: Jian-Ming Li, MD, PhD, FHRS, et al.
Published: (2020-03-01)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
by: Luis A. Pires
Published: (2007-08-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)

“I don’t know exactly what you’re referring to”: the challenge of values elicitation in decision making for implantable cardioverter-defibrillators
by: Carroll SL, et al.
Published: (2018-09-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
by: Janet K. Han, et al.
Published: (2022-02-01)